Filing Flows › Lucid Diagnostics (LUCD) › Q1 2026 › vs Q3 2025
Lucid Diagnostics (LUCD) Q1 2026 vs Q3 2025 (quarter over quarter)
Lucid Diagnostics's revenue fell $248K (-16%) from $1.5M in Q3 2025 to $1.3M in Q1 2026.
Lucid Diagnostics, Q1 2026: revenue $1.3M (+52% year over year), operating margin -964.5%, net loss $13.9M, operating cash flow −$12.1M. The chart draws each line against Q3 2025, the increases inside each band.
Every line
| Line | Q1 2026 | Q3 2025 | Change | % |
|---|---|---|---|---|
| Revenue | $1.3M | $1.5M | −$248K | -16% |
| Net loss | $13.9M | $16.3M | −$2.4M | -14% |
| Costs & expenses | $15.2M | $17.8M | −$2.6M | -15% |
| Operating costs | $13.4M | $15.5M | −$2.1M | -14% |
| Interest & other, net | $1.8M | $2.3M | −$460K | -20% |
| Research & development | $1.2M | $1.7M | −$517K | -30% |
| Sales & marketing | $5.0M | $5.3M | −$341K | -6% |
| General & admin | $5.4M | $6.5M | −$1.1M | -16% |
| Other operating costs | $105K | $2.0M | −$1.9M | -95% |
| Operating cash sources | $13.9M | $16.3M | −$2.4M | -14% |
| Depreciation & amortization | $222K | $209K | $13K | +6% |
| Share-based compensation | $1.4M | $1.2M | $246K | +21% |
| Working capital & other | $175K | $2.3M | −$2.1M | -92% |
| Cash used in operations | $12.1M | $12.6M | −$477K | -4% |
| Net loss absorbed | $13.9M | $16.3M | −$2.4M | -14% |
Questions
How much did Lucid Diagnostics's revenue grow quarter over quarter in Q1 2026?
Lucid Diagnostics's revenue fell $248K (-16%) from $1.5M in Q3 2025 to $1.3M in Q1 2026.